Fanjie Jin

ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour–stromal IL-1β/NF–κB/ESE3 signalling axis

Song Gao, Shengyu Yang, Chongbiao Huang, 2022, British Journal of Cancer.

Tumor-stromal IL-1β/ NFκB / ESE3 Signaling Axis Drives Pancreatic Cancer Fibrosis, Chemoresistance, and Poor Prognosis

Hongwei Wang, Song Gao, Shengyu Yang, 2020, bioRxiv.

Proteasome inhibitor MG132 suppresses pancreatic ductal adenocarcinoma-cell migration by increasing ESE3 expression

T. Zhao, Ming Yu, Di Xiao, 2019, Oncology letters.

Design, synthesis and biological evaluation of indoline derivatives as multifunctional agents for the treatment of ischemic stroke

Hongwei Wang, Jiaming Li, Shihui Qian, 2021, Medicinal Chemistry Research.

IL-37/ STAT3/ HIF-1α negative feedback signaling drives gemcitabine resistance in pancreatic cancer

Hongwei Wang, Song Gao, Shengyu Yang, 2020, Theranostics.

PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer.

Hongwei Wang, Song Gao, Hui Li, 2021, Cancer Letters.